CD74 is a potential biomarker predicting the response to immune checkpoint blockade

CD74 is a potential biomarker predicting the response to immune checkpoint blockade

Abstract Background Immune checkpoint blockade (ICB) has been improving the patient outcome in multiple cancer types. However, not all patients respond to ICB. Biomarkers are needed for selecting appropriate patients to receive ICB. CD74 is an important chaperone that regulates antigen presentation...

Full description

Bibliographic Details
Main Authors: Wen-Qi Shi, Dan-Xun Chen, Ze-Sen Du, Chun-Peng Liu, Tian-Tian Zhai, Feng Pan, Hai-Lu Chen, Wei-Nan Liao, Shao-Hong Wang, Jun-Hui Fu, Si-Qi Qiu, Zhi-Yong Wu
Format: Article
Language:English
Published: BMC 2024-10-01
Series:Cancer Cell International
Subjects:
Immunotherapy
CD74
Treatment response
Biomarker
Online Access:https://doi.org/10.1186/s12935-024-03524-w

Internet

https://doi.org/10.1186/s12935-024-03524-w

Similar Items